A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer

Name: A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer
Published: 2020
License: Public Domain

National Cancer Institute (NCI) · 2020

ClinicalTrials.gov · Datasets · License: Public Domain · 2020

Open Source ↗

endometrial high grade endometrioid adenocarcinoma, fallopian tube clear cell adenocarcinoma, fallopian tube endometrioid adenocarcinoma, fallopian tube high grade serous adenocarcinoma, fallopian tube malignant mixed mesodermal (mullerian) tumor, fallopian tube mucinous adenocarcinoma, fallopian tube transitional cell carcinoma, fallopian tube undifferentiated carcinoma, figo grade 1 endometrial endometrioid adenocarcinoma, figo grade 2 endometrial endometrioid adenocarcinoma, ovarian high grade serous adenocarcinoma, ovarian seromucinous carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 918170
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.